Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.

Acta oto-laryngologica - 1 Apr 2005

Kawano Toshirou, Yanoma Shunsuke, Nakamura Yoshiyasu, Ozeki Akemi, Kokatsu Toshiyuki, Kubota Akira, Furukawa Madoka, Tsukuda Mamoru

Abstract excerpt

CONCLUSION: The possible roles of CD44st, CD44v5 and CD44v6 in the prognosis of head and neck cancer deserve further elucidation and evaluation with long-term patient follow-up. OBJECTIVE: Standard CD44 (CD44st), CD44 variant 5 (CD44v5) and CD44 variant 6 (CD44v6) are expressed in human malignant cells and tissues. The mechanism of their expression remains unclear, but has been reported to be associated with the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Cell Adhesion Molecules

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Enzyme-Linked Immunosorbent Assay

Share to Hyaluronan Receptors

Share to Neoplasm Staging

Share to Reference Values

Share to Statistics as Topic

Source

Identifiers

PMID: 15823810
DOI: 10.1080/00016480510026971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.PMID 15823810Read ↗

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C44Mab-5Semantic proximity Read ↗

Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.Semantic proximity Read ↗

Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features.Semantic proximity Read ↗

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.Semantic proximity Read ↗

CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer CellsSemantic proximity Read ↗

[CD44 splice variants as prognostic factors in invasive cervix carcinoma].Semantic proximity Read ↗

Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.Semantic proximity Read ↗

The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.Semantic proximity Read ↗

The influence of CD44 splice variants to the outcome of patients with oral squamous cell carcinoma.Semantic proximity Read ↗

EXPRESSION OF CD44 SPLICE VARIANTS IN SQUAMOUS EPITHELIA AND SQUAMOUS CELL CARCINOMAS OF THE HEAD AND NECKSemantic proximity Read ↗

Characterization of CD44 variant expression in head and neck squamous cell carcinomasSemantic proximity Read ↗

Soluble CD44 splice variants in metastasizing human breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.